Meet Our Editorial Board Member
Journal:
Pharmaceutical Nanotechnology
Volume:
8
Page:
1-3
Author(s):
J. Guo
Recent Advances of Novel Therapeutic Agents from Botanicals for Prevention and Therapy of Breast Cancer: An Updated Review
Journal:
Current Cancer Therapy Reviews
Volume:
16
Page:
5-18
Author(s):
Namrata Singh, Poonam Kushwaha*, Amresh Gupta and Om Prakash
ERGIC3 Silencing Additively Enhances the Growth Inhibition of BFA on Lung Adenocarcinoma Cells
Journal:
Current Cancer Drug Targets
Volume:
20
Page:
67-75
Author(s):
Qiurong Zhao, Mingsong Wu, Xiang Zheng, Lei Yang, Zhimin Zhang, Xueying Li* and Jindong Chen*
Natural DNA Intercalators as Promising Therapeutics for Cancer and Infectious Diseases
Journal:
Current Cancer Drug Targets
Volume:
20
Page:
19-32
Author(s):
Martyna Godzieba* and Slawomir Ciesielski
The Correlation between EGFR and Androgen Receptor Pathways: A Novel Potential Prognostic Marker in Gastric Cancer
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
19
Page:
2097-2107
Author(s):
Shahrzad S. Fard, Kioomars Saliminejad, Masoud Sotoudeh, Niloofar Soleimanifard, Shaghayegh Kouchaki, Mansour Yazdanbod, Habibollah Mahmoodzadeh, Ardeshir Ghavamzadeh, Reza Malekzadeh, Bahram Chahardouli, Kamran Alimoghaddam* and Seyed H. Ghaffari*
The Pharmacogenomics “Side-effect” of TP53/EGFR in Non-small Cell Lung Cancer Accompanied with Atorvastatin Therapy: A Functional Network Analysis
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
19
Page:
2060-2071
Author(s):
Lei Zhang, Yifang Huang, Xuedong Gan, Siying He, Xiaohuan Cheng, Na Yang, Siwei Li, Zuhua Li and Fang Zheng*
Furanocoumarin A: A Novel Anticancer Agent on Human Lung Cancer A549 Cells from Fructus liquidambaris
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
19
Page:
2091-2096
Author(s):
Hui Fang and Hongmei Ji*
The Cold Case of Metabotropic Glutamate Receptor 6: Unjust Detention in the Retina?
Journal:
Current Neuropharmacology
Volume:
18
Page:
120-125
Author(s):
E. Palazzo*, S. Boccella, I. Marabese, G. Pierretti, F. Guida and S. Maione
Jab1-siRNA Induces Cell Growth Inhibition and Cell Cycle Arrest in Gall Bladder Cancer Cells via Targeting Jab1 Signalosome
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
19
Page:
2019-2033
Author(s):
Pratibha Pandey, Mohammad H. Siddiqui, Anu Behari, Vinay K. Kapoor, Kumudesh Mishra, Uzma Sayyed, Rohit K. Tiwari, Rafia Shekh and Preeti Bajpai*
Advances in the Treatment of Ovarian Cancer Using PARP Inhibitors and the Underlying Mechanism of Resistance
Journal:
Current Drug Targets
Volume:
21
Page:
167-178
Author(s):
Ling Wang, Qi Wang, Yangchun Xu, Manhua Cui and Liying Han*